Samuel O'Brient

Samuel O'Brient

Expertise: Global Financial Markets, Macroeconomics and Geopolitics

Education: BA, Economics & Political Science, Sarah Lawrence College; MSc, International Politics, Trinity College Dublin

Awards & Accomplishments: Published in Curlew Quarterly. Quoted in Forbes. Interviewed by Foreign Policy.

About Samuel
Samuel O’Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O’Brient writes a weekly column on recent political news that investors should be following.

From his early days at InvestorPlace, O’Brient found himself drawn to the booming world of electric vehicles and green energy. His coverage of mining and other battery components has made him an expert source for industry publications. During his early years as an Economic Policy Analyst at U.S. Resist News, he gained expertise in international trade as the U.S.-China trade war dominated headlines. This in-depth research and analysis experience helped strengthen his prowess in all things political economy. O’Brient brings this expertise to work with him every day, thoughtfully analyzing how the daily happenings on the Capitol trickle down to Wall Street… and how retail investors can take action to profit.

An experienced journalist, editor, and economic policy analyst, O’Brient has spent his career guided by a deep passion for economic theory and policy. As a financial blogger on TipRanks, he has received 4.6 stars and is ranked in the top 10% of stock pickers.

O’Brient’s work on economic and tech policy has been curated by popular outlets Marker, OneZero and Gen.

He can be reached on LinkedIn and Muck Rack.

Recent Articles

UAW Strike 2023 Update: What a Big Three Strike Means for Auto Stocks

The United Auto Workers (UAW) union is prepared to strike if companies don't meet its demands. Here's what this means for auto stocks.

Why the ‘Dumb Money’ Film Release Won’t Save GME or AMC Stock

"Dumb Money" just hit theaters, putting GameStop and AMC in full focus. Here's why investors shouldn't buy either GME stock or AMC.

Should You Buy NVO Stock Ahead of the Novo Nordisk Stock Split?

Ozempic producer Novo Nordisk is about to split its stock again. Here's why investors should be watching NVO stock closely.

Gary Gensler Addresses MMTLP Stock in New Hearing

SEC chair Gary Gensler recently spoke at a U.S. Senate hearing and addressed MMTLP stock. Unfortunately for investors, he couldn't say much.

NIO Stock Alert: Europe Is Cooking Up a Dangerous Storm for Nio and Its Peers

An investigation from the EU into China's EV sector is pushing stocks down today. Here's what this means for NIO stock and its peers.